Goff Brian
SEC Form 4 insider trading activity
Goff Brian has filed 4 SEC Form 4 filings (15 transaction rows) across 2 companies, including NTLA, AGIO, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Jun 10, 2026.
On the most recent filing, Goff Brian is listed as Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. Inside the rolling window, Goff Brian reported no open-market purchases and 3 open-market sales totaling $1.7M in AGIO. The largest disclosed transaction in the window is a sale of 19,068 AGIO shares on Apr 2, 2026, worth $662K.
Companies traded
Other insiders at NTLA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.7M
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Goff Brian made?
Goff Brian has filed 4 SEC Form 4 filings (15 transaction rows) across 2 companies, including NTLA, AGIO since 2026.
Which companies does Goff Brian trade?
Goff Brian has filed SEC Form 4 disclosures for 2 companies, including NTLA, AGIO.
When was Goff Brian's most recent SEC Form 4 filing?
Goff Brian's most recent SEC Form 4 filing on Tracefour is dated Jun 10, 2026.
What is Goff Brian's total buy and sell value in the current window?
Inside the rolling retention window, Goff Brian bought $0 and sold $1.7M based on SEC Form 4 filings.
What was Goff Brian's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 19,068 AGIO shares on 2026-04-02, worth $662K, per SEC Form 4 filings.